Loading...
Loading...
APDN| Name | Value |
|---|---|
| Revenues | 3,559.3K |
| Cost of Revenue | 3,142.6K |
| Gross Profit | 416.8K |
| Operating Expense | 4,786.2K |
| Operating I/L | -4,369.5K |
| Other Income/Expense | 3,704.9K |
| Interest Income | 1.4K |
| Pretax | -664.6K |
| Income Tax Expense | 108.5K |
| Net Income/Loss | -773.1K |
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for supply chain security, anti-counterfeiting, and anti-theft purposes. Their SigNature molecular tags and SigNify IF portable DNA readers provide forensic protection and real-time authentication in the field. The company also offers COVID-19 PCR-based molecular diagnostic test kits and preclinical contract research and manufacturing services for nucleic acid-based therapeutic markets. Additionally, they are developing invasive circulating tumor cell capture and identification technology. Applied DNA Sciences generates revenue through the sale of molecular tags, DNA readers, diagnostic test kits, and contract research services.
